Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Glossary:TAG-00008-Cli-ngK

From GxPlex

Revision as of 17:29, 15 July 2026 by imported>GxPlexBot (Import from GxPlex Excel)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Glossary > Clinical trial

Clinical trial
Tag-ID TAG-00008-Cli-ngK
English Clinical trial / Clinical study
EN Abbr. CT
French Essai clinique / Étude clinique
FR Abbr. EC
German Klinische PrĂźfung / Klinische Studie
DE Abbr. KP

References

 ScopeDocument partLanguageDocument
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 4 Absatz 23HM§ 4 Absatz 23DEDEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40G§ 40DEDEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40aG§ 40aDEDEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b Absatz 5HM§ 40b Absatz 5DEDEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b-001G§ 40bDEDEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 41HM§ 41DEDEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 41aG§ 41aDEDEU AMG - Arzneimittelgesetz 19-Jul-2023
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 42cHM§ 42cDEDEU AMG - Arzneimittelgesetz 19-Jul-2023
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 11GArticle 11ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 2HMArticle 2

Paragraph 2

No. 2		ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 4HMArticle 2

Paragraph 2

No. 4		ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 28 Paragraph 1HMArticle 28 Paragraph 1ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 31 Paragraph 2-3HMArticle 31 Paragraph 2-3ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 33HMArticle 33ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 34HMArticle 34ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 4GArticle 4ENEU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022
GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (a)HMArticle 2 (a)ENGBR Directive 2001/20/EC 04-Apr-2001
GBR NIHR - National Institute for Health and Care Research 28-Jan-2025 -G-ENGBR NIHR - National Institute for Health and Care Research 28-Jan-2025
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11 - 12HMArticle 11 - 12ENGBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 clinical trialHMArticle 2 clinical trialENGBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 relevant ethics committeeHMArticle 2 relevant ethics committeeENGBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 3 (1) - (5)HMArticle 3 (1) - (5)ENGBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2HMSchedule 1 Part 2ENGBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 IntroductionGAnnex 2 IntroductionENICH ICH E6 Guideline - Annex 2 R3 Annex 2
ICH ICH E6 Guideline R3 (2025) GLOSSARY - Clinical TrialGGLOSSARY - Clinical TrialENICH ICH E6 Guideline R3 (2025)
ICH ICH E7 Guideline 1993 -G-ENICH ICH E7 Guideline 1993
ICH ICH E9 Guideline - Addendum R1 20-Nov-2019 -HM-ENICH ICH E9 Guideline - Addendum R1 20-Nov-2019
USA 45 CFR Part 46 09-Apr-2025 § 46.102 (b)G§ 46.102 (b)ENUSA 45 CFR Part 46 09-Apr-2025
USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018 -G-ENUSA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018
WHO WHO - Guidance for best practices for clinical trials 2024 1.4G1.4ENWHO WHO - Guidance for best practices for clinical trials 2024
WHO WHO - Guidance for best practices for clinical trials 2024 2.4G2.4ENWHO WHO - Guidance for best practices for clinical trials 2024
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - clinical trialHMGlossary - clinical trialENWHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - clinical trial PhasesHMGlossary - clinical trial PhasesENWHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995
Retrieved from "https://gxplex.org/index.php?title=Glossary:TAG-00008-Cli-ngK&oldid=15543"